retatrutide phase 3 triumph A summary slide of the TRIUMPH-1 data presented today by Dr. Ania Jastreboff at #ADA2026 🚨 TRIUMPH-1: Obesity Trial with Retatrutide 🚨 Retatrutide 💉, a once-weekly triple hormone receptor Retatrutide just delivered the first

Each pen contains one dose, so youll need four pens for a 30-day supply

Gabriella Baran and our wellness team Complete health monitoring for your safety and optimal results Nutrition and exercise guidance designed to improve weight loss and maintain muscle Ongoing adjustments to dosage as your body changes Holistic focus on long-term vitality, not quick fixes Your Elev care team works with you to achieve results that look and feel healthy

Wegovy should not be used in patients with a history of severe allergic reactions to Semaglutide or in patients with a personal or family history of medullary thyroid carcinoma or a rare condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

It is FDA-approved specifically for HIV-associated lipodystrophy and is not approved for general weight loss

Pancreatitis: As with all GLP-1 receptor agonists, there is a theoretical risk of acute pancreatitis

Its a GLP-1 receptor agonist and works by reducing appetite